WBC disorders

WBC Disorders

Overview of Diseases of WBCs

  • Several diseases affect white blood cells (WBCs), including infectious mononucleosis, myelodysplastic syndrome, leukemias, lymphomas (such as Hodgkin and Non-Hodgkin Disease), and multiple myeloma.

Infectious Mononucleosis ("Mono")

  • Classification: Self-limiting lymphoproliferative disorder.

  • Pathophysiology: Infection of B lymphocytes due to the Epstein-Barr virus (EBV).

  • Epidemiology:   - Most prevalent in adolescents and young adults.   - Main transmission route: EBV-contaminated saliva.

  • Pathogenesis: Involves proliferation of atypical lymphocytes.

  • Onset:   - Insidious onset with an incubation period of 4-8 weeks.

Clinical Manifestations of Infectious Mononucleosis

  • Symptoms:   - Lymphadenopathy (swelling of lymph nodes).   - Hepatitis (liver inflammation).   - Splenomegaly (enlarged spleen).

  • Laboratory Findings:   - White blood cell (WBC) count increases to approximately 12,000 - 18,000 cells per microliter, with about 95% lymphocytes.

  • Acute Phase Duration: 2-3 weeks.

  • Post-Acute Symptoms: Some degree of debility or lethargy lasting 2-3 months.

  • Treatment: Symptomatic and supportive management.

Myelodysplastic Syndrome

  • Definition: A group of related hematologic disorders characterized by alterations in the quantity and quality of bone marrow elements.

  • Demographics: Primarily affects elderly individuals (age > 65).

  • Clinical Manifestations:   - Cytopenias (reduction in blood cell types):     - Anemia.     - Increased susceptibility to infections.     - Spontaneous bleeding or bruising.

  • Etiology: Unknown, but environmental triggers may play a role.

Diagnostics and Treatment for Myelodysplastic Syndrome

  • Diagnostics:   - Combination of laboratory tests and bone marrow biopsy.

  • Treatment:   - Dependent on disease severity, may include:     - Supportive care.     - Granulocyte colony-stimulating factor (G-CSF).     - Erythropoietin.     - Chemotherapy.     - Bone marrow transplant.

Leukemias

  • Overview: Malignant neoplasms derived from a single hematopoietic cell line.

  • Characteristics of Leukemic Cells:   - Immature and unregulated (undifferentiated).   - Proliferate within the bone marrow.   - Circulate in blood and infiltrate spleen and lymph nodes.   - Present in both children and adults.

Leukemia Classifications

  • Classification Criteria: Based on predominant cell type and whether the condition is acute or chronic.   - Acute Lymphocytic (Lymphoblastic) Leukemia (ALL): Most common in childhood.   - Chronic Lymphocytic Leukemia (CLL): Most common in older adults.   - Acute Myelocytic Leukemia (AML): Predominantly affects adults.   - Chronic Myelocytic Leukemia (CML): Affects both adults and children.

Pathogenesis of Leukemia

  • Causes: Unknown; however, increased exposure to radiation has been identified as a potential factor.

  • Pathophysiology:   - Leukemic cells are immature WBCs capable of rapid proliferation and have prolonged life spans.   - These cells cannot perform the functions of mature leukocytes (e.g., ineffective as phagocytes).   - They interfere with normal bone marrow cell maturation, including red blood cells (RBCs) and platelets.

Acute Leukemia

  • Onset: Sudden and stormy presentation.

  • Symptoms & Signs (S/S):   - Decreased levels of mature WBCs, RBCs, and platelets.   - ALL accounts for approximately 80% of childhood acute leukemias.   - AML is primarily an adult disease.

  • Diagnosis:   - Based on blood and bone marrow tissue analysis; presence of immature WBCs (blasts), which may comprise 60-100% of cells.

Chronic Leukemia

  • Onset: More gradual and insidious.

  • Discovery: May be incidentally found during routine blood tests.

  • Characteristics:   - CLL commonly occurs in older adults and displays relatively mature lymphocytes that are immunologically incompetent.   - CML can occur in both adults and children, typically shows leukocytosis with immature cell types.

Treatment of Leukemias

  • Primary Goal: Achieve remission.

  • Treatment Options:   - Cytotoxic chemotherapy.   - Stem cell transplantation:     - Allogeneic (from a volunteer donor).     - Syngeneic (from an identical twin).     - Autologous (from the patient's own cells).

  • Risks: Includes infection, rejection, and relapse.

Bone Marrow Biopsy Findings in Leukemia

  • Expected findings may include:   - Immature WBCs.   - Neutrophils.   - Red blood cells.   - Macrophages.

Malignant Lymphomas

  • Definition: Neoplasms of cells derived from lymphoid tissue.

  • Types: Hodgkin Disease and Non-Hodgkin Disease.

Hodgkin Disease

  • Characteristics:   - Typically presents with painless, progressive, rubbery enlargement of a single node or a group of nodes, commonly in the neck.   - Features a distinctive Reed-Sternberg cell found upon lymph node biopsy.

  • Diagnosis:   - Utilizes peripheral blood analysis (abnormal CBC), lymph node biopsy, bone marrow examination, and radiographic evaluation (CT, MRI, PET).

  • Etiology: Unknown; however, potential involvement of Epstein-Barr virus, genetic predisposition, and environmental toxins is considered.

Clinical Manifestations of Hodgkin Disease

  • Symptoms: Insidious onset; painless enlarged lymph nodes along with nonspecific symptoms.

  • Treatment Options:   - Chemotherapy.   - Radiation therapy.   - Stem cell transplant.

  • Prognosis: Generally good, as the disease tends to spread slowly and predictably.

Non-Hodgkin Disease

  • Characteristics:   - Another neoplastic disorder of lymphoid tissue.   - Spreads early, often to liver, spleen, and bone marrow.   - Also presents with painless superficial lymphadenopathy and extranodal symptoms.

  • Etiology: Unknown; the majority of patients have widely disseminated disease at diagnosis.

Clinical Manifestations of Non-Hodgkin Disease

  • Symptoms: Painless lymph node enlargement and nonspecific symptoms.

  • Diagnosis: Similar to Hodgkin’s lymphoma, with additional increased extranodal sites.

  • Treatment Options:   - Chemotherapy.   - Radiation.   - Stem cell transplant in refractory cases.   - Biologic drug therapy.

  • Prognosis: Generally poorer than Hodgkin Disease due to quicker and less predictable spread.

Lymphadenopathy Overview

  • Common Locations:   - Cervical nodes.   - Thymus.   - Axillary nodes.   - Inguinal nodes.   - Spleen.   - Diaphragm.

Lymphadenopathy - Cervical Location

  • Primary affected area when assessing lymphadenopathy, often the first region evaluated during examinations.

Key Differences Between Hodgkin's and Non-Hodgkin's Lymphoma

  • Differences:   - Etiology remains unknown for both diseases.   - Both require chemotherapy as a treatment.   - Abnormal lab values in CBC are observed.   - Presence of Reed-Sternberg cells is specific to Hodgkin’s lymphoma.

Multiple Myeloma

  • Definition: A type of cancer that affects plasma cells, specifically the proliferation of abnormal immunoglobulins, characterized here as “M protein” (a monoclonal antibody).

  • Pathophysiology:   - Malignant cells invade bone, leading to increased osteoclast activity, which results in bone destruction or resorption.   - Patients are unable to maintain adequate humoral immunity.

  • Demographics: More common in men than women (2:1 ratio), average age of onset is 65 years, with African Americans being affected more than Whites.

  • Etiology: Currently unknown.

Clinical Manifestations of Multiple Myeloma

  • Symptoms: Slow, insidious onset characterized by skeletal pain, bone pain, and potential hypercalcemia.

Diagnostics for Multiple Myeloma

  • Laboratory Findings:   - Monoclonal antibody protein in serum and urine.   - Presence of Bence Jones proteins in urine.   - Pancytopenia (decrease in all blood cell types).   - Hypercalcemia.   - Elevated serum creatinine levels.   - Radiographic results may show osteolytic lesions.

Treatment Options for Multiple Myeloma

  • Management Approaches:   - Monitoring (watchful waiting).   - Corticosteroids.   - Chemotherapy.   - Biologic therapy.   - Stem cell transplant.   - Use of bisphosphonates to manage bone integrity.   - Ensure adequate hydration, particularly in light of renal concerns.

Multiple Myeloma - Osteolytic Lesions

  • Characteristics: Associated with bone-related damage that can lead to fractures and contribute to overall skeletal pain.

Summary of Leukemias and Associated Disorders

  • Cellular Overview:   - Various types of leukemias including acute, chronic lymphocytic, and acute lymphoblastic leukemias.   - Associated malignancies such as Non-Hodgkin lymphoma and multiple myeloma.

Frequently Asked Questions

  • Common Manifestations of Multiple Myeloma:   - Symptoms may include lymphadenopathy, presence of "blasts", splenomegaly, and notably bone pain.

References